Skip to content

Ayurvedic drug for Vyanga.

"PHARMACOGNOSTICAL AND COMPARATIVE CLINICAL STUDY OF KADAMBA (Anthocephalus cadamba (Roxb)Miq)STEM BARK AND LEAF IN VYANGA". - nil

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/03/064854
Enrollment
40
Registered
2024-03-27
Start date
Unknown
Completion date
Unknown
Last updated
2024-04-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L814- Other melanin hyperpigmentation

Interventions

None listed

Sponsors

DR ARABATI KAVYA RASHMIKA
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients with signs and symptoms of vyanga. 2.Shyava varna yukta, niruja mandalas, parushatva present on face. 3.Skin patch test for assessment of sensitivity.

Exclusion criteria

Exclusion criteria: 1.Hyperpigmentation caused since birth. 2.Patients with psychosomatic disorders. 3.Pregnant women and lactating mothers. 4.patients suffering with chronic illness like Thyroid, CKD, CAD, HIV .

Design outcomes

Primary

MeasureTime frame
1.To decrease the size and number of dark brown color patches on face. 2.To reduce the roughness on face.Timepoint: 0, 15th day,30th day, 45th day, 60th day.

Secondary

MeasureTime frame
1. To improve complexion on face.Timepoint: 0,15th day,30th day,45th day,60th day.

Countries

India

Contacts

Public ContactDr GATTU SWARUPA RANI

DR BRKR GOVT AYURVEDIC MEDICAL COLLEGE

gattusr135@gmail.com9441905338

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026